Manufacturing and Allied · EQUITY
CARB
Carbacid Investments Plc
Ksh 41.90
▼1.64% today
close 06 Nov 2026 · source mystocks
68 owned trading days · 07 Jul 2026 → 06 Nov 2026 · KES 34.80–48.70
Why grade C: newest statement 25 months old · only 2 FYs of history (need 3)
Automated analysis for information & education. Not investment advice.
The five pillars
composite —/100Data C
scored 06 Nov 2026 · weights profile Manufacturing and Allied · formulas on /methodology
Ring color: accent = confidence A/B, amber = C/D — a fixed-radius stroke, never a percentage fill.
Value20
- P/E 26.70 ·w25
- P/B 2.1240 ·w20
- earnings yield 3.7% vs 364d T-bill 9.03% (spread -5.3pp)0 ·w20
- needs positive EPS and own P/E history— ·w15
- needs a dividend and own yield history— ·w10
- revenue/earnings growth +11.3% YoY71 ·w10
Financial health92
- F-Score 8/9 signals passed89 ·w70
- interest coverage 55.0× (stored ratio — not derivable from raw lines)100 ·w30
Quality69
- ROE 7.9%32 ·w25
- net margin 30.8% (non-financial bands)100 ·w20
- net margin +1.6pp over window(short window)66 ·w15
- ROA 6.9%48 ·w15
- debt/equity 0.15× (standard bands)95 ·w15
- revenue never declined over window(short window)100 ·w10
Dividend reliability83
- paid a dividend in 2 of 2 observed FYs (design window 5)(short window)100 ·w30
- yield 1.6% at current price19 ·w20
- earnings cover the dividend 2.42×95 ·w20
- never cut over 2 observed FYs(short window)100 ·w15
- payout ratio 41% of earnings100 ·w15
MomentumBuilding history — since 2026-07-07
- Building history — since 2026-07-07— ·w100
Liquidity53
- median daily turnover ≈ KES 1,066,538 over 68 observed days(short window)51 ·w40
- no trades on 0% of observed days(short window)100 ·w30
- daily turnover 1.0bp of market cap (shares est. from NI÷EPS)(short window)10 ·w30
Statements we hold
| FY | Revenue | Net income | EPS | DPS |
|---|---|---|---|---|
| 2024 | KES 1.3B | KES 400.0M | 1.57 | 0.65 |
| 2023 | KES 1.2B | KES 350.0M | 1.37 | 0.60 |
source v3-seed (vintage 2026-02) · refreshed per filing as filings are processed
Analyst brief
Carbacid Investments trades at 41.3 KES with an earnings yield of 3.8%, sitting 5.2 percentage points below the 364-day T-bill rate of 9.03%. The health pillar ranks strongest, scoring 92, driven by an F-Score of 8/9 and interest coverage of 55.0×, both signalling robust operational and balance-sheet strength. Quality follows at 69, anchored by a net margin of 30.8% and debt-to-equity of 0.15×, though return on equity of 7.9% lags. The value pillar scores lowest at 21: a P/E of 26.3 and earnings yield well below the risk-free rate weigh heavily, though revenue and earnings grew 11.3% year-on-year. Dividend policy ranks at 83, reflecting consistent payments over two observed years with a payout ratio of 41% and 2.42× earnings cover; momentum data remains too new to score.
An overall verdict is withheld due to low confidence: the newest financial statement is 25 months old and only two years of history are available (three are needed for full assessment). Liquidity is moderate at 53, with median daily turnover around 1 million KES but minimal depth relative to market capitalisation. No risk flags appear in the data. The confidence grade is C. A fresh annual filing would anchor expectations on earnings sustainability and runway; observing the consistency of dividend policy and margins over a third year would materially strengthen conviction in any direction.
Automated analysis for information & education. Not investment advice.
generated 02 Nov 2026, 17:47 EAT · every figure machine-checked against the engine's computed inputs · identical for all readers